triazoles has been researched along with quinpirole in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (33.33) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fenu, S; Morelli, M; Ongini, E; Pinna, A | 1 |
Cristalli, G; Morelli, M; Pinna, A; Wardas, J | 1 |
Acquas, E; Di Chiara, G; Fenu, S; Loddo, P | 1 |
Pèzzola, A; Popoli, P; Reggio, R | 1 |
Boehm, S; Freissmuth, M; Just, H; Klinger, M; Korkhov, VM; Kudlacek, O; Nanoff, C; Pankevych, H; Vartian, N; Yang, Q | 1 |
Belcastro, V; Borsini, F; Calabresi, P; Centonze, D; Costa, C; Picconi, B; Tantucci, M; Tozzi, A; Tscherter, A | 1 |
Baraldi, PG; Fenu, S; Morelli, M; Simola, N; Tabrizi, MA | 1 |
Bhattacharjee, AK; Chen, X; Jacobson, KA; Jacobson, O; Kiesewetter, DO; Lang, L; Ma, Y; Niu, G; Shinkre, B; Trenkle, WC | 1 |
Feng, LY; Huang, L; Wu, DD; Zhang, L | 1 |
9 other study(ies) available for triazoles and quinpirole
Article | Year |
---|---|
Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats.
Topics: Animals; Behavior, Animal; Brain Diseases; Dopamine Agonists; Drug Synergism; Gene Expression; Genes, fos; Levodopa; Male; Oxidopamine; Proto-Oncogene Proteins c-fos; Purinergic P1 Receptor Antagonists; Pyrimidines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Dopamine D2; Substantia Nigra; Triazoles | 1997 |
Adenosine A2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Dopamine Agonists; Immunohistochemistry; Limbic System; Male; Oxidopamine; Phenethylamines; Proto-Oncogene Proteins c-fos; Purinergic Antagonists; Purinergic P1 Receptor Agonists; Pyrimidines; Quinpirole; Rats; Rats, Sprague-Dawley; Triazoles | 1997 |
A within-subjects microdialysis/behavioural study of the role of striatal acetylcholine in D1-dependent turning.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Animals; Apomorphine; Dizocilpine Maleate; Dopamine Agonists; Excitatory Amino Acid Antagonists; Indoles; Male; Medial Forebrain Bundle; Microdialysis; Neostriatum; Neuroprotective Agents; Phenanthridines; Pyrimidines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior; Sympathectomy, Chemical; Triazoles | 1999 |
Effects of SCH 58261, an adenosine A(2A) receptor antagonist, on quinpirole-induced turning in 6-hydroxydopamine-lesioned rats. Lack of tolerance after chronic caffeine intake.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Caffeine; Central Nervous System Stimulants; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Male; Motor Activity; Neuroprotective Agents; Parkinson Disease; Purinergic P1 Receptor Antagonists; Pyrimidines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Time Factors; Triazoles | 2000 |
The human D2 dopamine receptor synergizes with the A2A adenosine receptor to stimulate adenylyl cyclase in PC12 cells.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenine; Adenosine; Adenosine Deaminase; Adenosine Diphosphate; Adenylyl Cyclases; Animals; Benzamides; Binding, Competitive; Cell Cycle; Cell Membrane; Cofilin 1; Colforsin; Cyclic AMP; Cytoskeletal Proteins; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Enzyme Activation; Gene Expression; Glutamic Acid; Humans; Membrane Potentials; Patch-Clamp Techniques; PC12 Cells; Pertussis Toxin; Phenethylamines; Phosphodiesterase Inhibitors; Phosphoproteins; Propionates; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrrolidines; Quinpirole; Radioligand Assay; Rats; Receptors, Dopamine D2; Receptors, Purinergic P1; Thionucleotides; Transfection; Triazines; Triazoles; Xenopus Proteins | 2003 |
Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission.
Topics: Adenine; Adenosine; Animals; Cerebral Cortex; Corpus Striatum; Dopamine Agonists; Excitatory Postsynaptic Potentials; Glutamic Acid; Male; Neurons; Organ Culture Techniques; Patch-Clamp Techniques; Phenethylamines; Quinpirole; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptors, Dopamine D2; Synaptic Transmission; Triazines; Triazoles | 2007 |
Blockade of globus pallidus adenosine A(2A) receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D(1) or D(2) dopamine receptor agonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Dopamine Agonists; Globus Pallidus; Hydroxydopamines; Male; Neuroprotective Agents; Parkinson Disease, Secondary; Pyrimidines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Rotation; Stereotyped Behavior; Sympathectomy, Chemical; Triazoles | 2008 |
Striatal adenosine A(2A) receptor-mediated positron emission tomographic imaging in 6-hydroxydopamine-lesioned rats using [(18)F]-MRS5425.
Topics: Animals; Autoradiography; Biological Transport; Injections; Male; Neostriatum; Oxidopamine; Positron-Emission Tomography; Pyrazoles; Pyrimidines; Quinpirole; Raclopride; Radiochemistry; Rats; Receptor, Adenosine A2A; Triazoles | 2011 |
Modulation of A₂a receptor antagonist on D₂ receptor internalization and ERK phosphorylation.
Topics: Adenosine A2 Receptor Antagonists; Animals; Arrestins; beta-Arrestins; Bioluminescence Resonance Energy Transfer Techniques; Cells, Cultured; Corpus Striatum; Extracellular Signal-Regulated MAP Kinases; HEK293 Cells; Humans; Neurons; Phosphorylation; Protein Multimerization; Quinpirole; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Dopamine D2; src-Family Kinases; Triazines; Triazoles | 2013 |